Expedition Medicines is building AI to expand the boundaries of medicine. Its quantum chemistry AI platform, powered by an industry-leading chemoproteomics data generation engine, learns the rules of molecular reactivity to generate small molecule drugs against disease-driving proteins that have long been considered undruggable. The platform has enabled the creation of a pipeline of potential first-in-class therapies across oncology, immunology, and other well-defined diseases. Expedition was founded by Flagship Pioneering in 2022.